Skip to content

    Announcements

    Exciting News for WebMD Members!

    We've been busy behind the scenes building new message boards for you. You'll have new and easier ways to find messages, connect with others, and share your stories.

    And, this will all be available on your smartphone or other mobile device!

    What Do You Need to Do?

    The message board you're used to will be closing in the coming weeks. While many of your boards will be making the move to our new home, your posts will not. Want to keep a discussion going? Save posts you want to continue (this includes your member profile story), so that you can re-post them in the new message boards.

    Keep an eye here and on your email inbox, we'll be back in touch soon to give you all the information you need!


    Yours in health,
    WebMD Message Boards Management

    Betaseron is not working out for me.
    avatar
    TotallyDisgusted1 posted:
    Betaseron is not working out for me, I have asked my neuro if there was a pill form DMD, he told that there were many options and wants to talk to me about them. Before I talk to him I wanted to ask if anyones experiences with the pill form.


    Are the pill DMD just as good as the injectable DMD? and are there better ones then others, and ones that I should stay away from do to bad side effects.

    Thanks in advance

    -Rob
    Reply
     
    avatar
    hackwriter responded:
    Dear Rob,

    There are two oral therapies on the market right now, Gilenya and Aubagio. They both carry risks; Gilenya can slow heart rate and cause organ damage. Aubagio carries the risk of liver toxicity and damage. See links to info about these two drugs below:
    http://www.medicalnewstoday.com/articles/250293.php

    http://www.webmd.com/multiple-sclerosis/news/20100922/gilenya-first-oral-ms-drug-gets-fda-nod

    Another oral therapy that will come on the market in early 2013 is BG-12, which has demonstrated no health risks in clinical trials and only minor side effects. This is the one I've been waiting for because of its excellent safety profile. See link to info about BG-12 below:

    http://www.msrc.co.uk/index.cfm/fuseaction/show/pageid/1679

    These oral therapies have demonstrated greater than 45% reduction in relapses and/or new lesions compared to control groups. These reduction rates are higher than those measured in clinical trials for all the injectible therapies.

    However, there is no way to determine how a therapy will work for you until you try it--and so it is impossible to advise anyone about which one is "the better therapy." A lot of people do very well with Tysabri or Avonex or Copaxone or whichever of the therapies they have tried and which seem to work for them. How you tolerate a therapy is individual as well.

    So, yes, you have a lot of choices and more to come. Please let us know how that talk with your doctor turns out.

    Kim


    Featuring Experts

    Stephanie knows multiple sclerosis as a patient and as a nurse. Stephanie was diagnosed with multiple sclerosis in 2013. Shortly after being diagnosed...More

    Helpful Tips

    the walking drug, ampyra
    was diagnosedwith MS in 2000. my walking has been getting harder to do but i was still able to work. i recently had an exacerbation of my ... More
    Was this Helpful?
    52 of 63 found this helpful

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.